Dr. Soma Sengupta, Division Chief of Neuro Oncology and Vice Chair of Research in the Department of Neurosurgery at UNC Health has been nominated to the committee of British Neuro-Oncology Society (BNOS).  

 BNOS is the leading multi-professional organization in the United Kingdom dedicated to promoting neuro-oncology research, education, and patient centered care. Dr. Sengupta spent her most formative years in the United Kingdom and attended the University of Wales for a Bachelor of Science in Biochemistry, then the University of Cambridge for medical school and a PhD in Natural Sciences. During her medical training, Dr. Sengupta was an active participant in membrane protein biology and immunology research at the Cambridge Institute of Medical Research with her mentor, Professor Paul Lehner. 

About Dr. Soma Sengupta
Dr. Soma Sengupta, MD, PhD, MBA, FRCP, FANA, FAAN is a board-certified neurologist, a fellowship-trained, sub-specialty board-certified neuro-oncologist, and is fellowship-trained in integrative medicine. She is a physician-scientist, clinical trialist specializing in brain tumor treatment and research with over 90 publications on translational research, clinical trials, case reports, and healthcare policy. Dr. Sengupta currently co-runs one of the UNC Brain Tumor Translational Research Program’s (SoDa Lab) with her spouse, Dr. Daniel Pomeranz-Krummel. The lab’s research focuses on brain cancers, both primary and metastatic. She is often engaged in talking to international brain tumor patients and helps navigating their care pathways.  

 About British Neuro-Oncology Society
The British Neuro-Oncology Society (BNOS) has its origins in the British Glioma Group that was formed in 1980 as a forum for basic scientists. In 1989, the group’s name changed to the British Neuro Oncology Group in order to recognize the inclusion of tumors other than glioma, then became the British Neuro-Oncology Society in 2004. BNOS hosts an annual meeting to facilitate effective interaction and collaboration between the diverse neuro-oncology disciplines, and fosters education and training for junior scientists and clinicians. BNOS also acts as the voice of neuro-oncology in the political process to increase research funding and up-to-date utilization of treatments and techniques in clinical practice.   

Article by: Makenzie Hardy, Marketing Coordinator, UNC Health Department of Neurosurgery